ASCO 2017: Updates on HER2-Positive Breast Cancer Treatment

June 13, 2017

This video highlights the latest studies presented at the 2017 ASCO Annual Meeting on the treatment of HER2-positive breast cancer.

In this video, Karen Gelmon, MD, of the British Columbia Cancer Agency in Canada, highlights the latest studies on the treatment of HER2-positive breast cancer presented at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 2–6 in Chicago.

Gelmon chaired an education session at the meeting on the optimal management of early and advanced HER2-positive breast cancer.